Viewing Study NCT00475150


Ignite Creation Date: 2025-12-24 @ 5:24 PM
Ignite Modification Date: 2026-01-03 @ 7:07 AM
Study NCT ID: NCT00475150
Status: COMPLETED
Last Update Posted: 2017-02-15
First Post: 2007-05-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Sponsor:
Organization: